OOIR: Observatory of International Research

Papers

(The median citation count of Current HIV/AIDS Reports is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation	90
Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions	78
Artificial Intelligence and Machine Learning for HIV Prevention: Emerging Approaches to Ending the Epidemic	59
The Impact of COVID-19 on HIV Care Provided via Telemedicine—Past, Present, and Future	54
ART Adherence Among Men Who Have Sex with Men Living with HIV: Key Challenges and Opportunities	36
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies	33
COVID-19 Outcomes and Risk Factors Among People Living with HIV	31
Understanding Engagement in HIV Programmes: How Health Services Can Adapt to Ensure No One Is Left Behind	30
A Review of Interventions to Enhance HIV Medication Adherence	29
Global Systematic Review of Common Mental Health Disorders in Adults Living with HIV	27
Social Network Interventions for HIV Transmission Elimination	26
Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine	24
A Review of Usability Evaluation Methods and Their Use for Testing eHealth HIV Interventions	23
NASH in HIV	23
The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management	23
Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations	22
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa	22
Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection	22
The Past, Present, and Future of PrEP implementation Among People Who Use Drugs	22
Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer	21
Latency Reversal 2.0: Giving the Immune System a Seat at the Table	20
Exploring Relative Preferences for HIV Service Features Using Discrete Choice Experiments: a Synthetic Review	20
A Cascade of Interventions to Promote Adherence to Antiretroviral Therapy in African Countries	19
Dysfunctional Immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases	19
A Systematic Review of Technology-Assisted HIV Testing Interventions	19

Frailty in People Living with HIV	19
Probing the Interface of HIV and Inflammaging	18
Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention	18
A Systematic Review of Recent Methodological Approaches for Using Ecological Momentary Assessment to Examine Outcomes in U.S. Based HIV Research	17
Gastrointestinal Dysfunction and HIV Comorbidities	17
PrEP Product Acceptability and Dual Process Decision-Making Among Men Who Have Sex with Men	16
Peer Group Focused eHealth Strategies to Promote HIV Prevention, Testing, and Care Engagement	15
Implementing a Status-Neutral Approach to HIV in the Asia-Pacific	15
Machine Learning and Clinical Informatics for Improving HIV Care Continuum Outcomes	15
The Evidence for HIV Self-Testing to Increase HIV Testing Rates and the Implementation Challenges that Remain	15
Frailty and HIV: Moving from Characterization to Intervention	15
Mind the Gap: HIV Prevention Among Young Black Men Who Have Sex with Men	15
Patient-Led Decision-Making for HIV Preexposure Prophylaxis	14
PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa	14
Community-Led Monitoring: When Community Data Drives Implementation Strategies	14
Social Determinants of Disease: HIV and COVID-19 Experiences	13
Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)	13
The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, Canada	13
Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men	12
Social and Behavioral Impacts of COVID-19 on People Living with HIV: Review of the First Year of Research	12
Interventions Addressing Depression and HIV-Related Outcomes in People with HIV	12
Non-communicable Diseases in Pregnant and Postpartum Women Living with HIV: Implications for Health Throughout the Life Course	12
Telehealth Interventions for HIV in Low- and Middle-Income Countries	11
People living with HIV and the emerging field of chronic pain—what is known about epidemiology, etiology, and management	11
Ethical Considerations in HIV eHealth Intervention Research: Implications for Informational Risk in Recruitment, Data Maintenance, and Consent Procedures	11
Immunomodulatory and Anti-Inflammatory Strategies to Reduce Comorbidity Risk in People with HIV	11
Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials	10
Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure	10
Aging with HIV in Latin America and the Caribbean: a Systematic Review	10
Sex Differences in the Treatment of HIV	10
Trauma-Informed HIV Care Interventions: Towards a Holistic Approach	10
Neuroimaging the Neuropathogenesis of HIV	10
HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies	10
Cost-Effectiveness Analysis in Implementation Science: a Research Agenda and Call for Wider Application	10
Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research	10
Technology-Delivered Intervention Strategies to Bolster HIV Testing	10
Socioeconomic Burdens of the COVID-19 Pandemic on LMIC Populations with Increased HIV Vulnerabilities	10
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups	10
Undernutrition and HIV Infection in Sub-Saharan Africa: Health Outcomes and Therapeutic Interventions	9
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review	9
The Brain Retains: Nonhuman Primate Models for Pediatric HIV-1 in the CNS	9
Cognitive and Neurologic Rehabilitation Strategies for Central Nervous System HIV Infection	9
Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines	9
Improving Care Outcomes for PLWH Experiencing Homelessness and Unstable Housing: a Synthetic Review of Clinic-Based Strategies	9
HIV Pathogenesis in the Human Female Reproductive Tract	9
Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?	9
The CAN-DO-IT Model: a Process for Developing and Refining Online Recruitment in HIV/AIDS and Sexual Health Research	9
From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation	8
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?	8
HIV Testing Uptake According to Opt-In, Opt-Out or Risk-Based Testing Approaches: a Systematic Review and Meta-Analysis	8

Relapse of Symptomatic Cerebrospinal Fluid HIV Escape	8
Contribution of Behavioral Health Factors to Non-AIDS-Related Comorbidities: an Updated Review	8
Senotherapeutics and HIV-1 Persistence	8
Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review	8
Application of the Consolidated Framework for Implementation Research to Facilitate Violence Screening in HIV Care Settings: a Review of the Literature	8
Overcoming Vaccine Hesitancy for Future COVID-19 and HIV Vaccines: Lessons from Measles and HPV Vaccines	8
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups	8
Application of Pathogen Discovery/Metagenomic Sequencing in CNS HIV	8
Utility of Short Message Service (SMS) for Remote Data Collection for HIV in Low- and Middle-Income Countries	7
Ethical Implications of eHealth Tools for Delivering STI/HIV Laboratory Results and Partner Notifications	7
Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?	7
Recruitment of US Adolescents and Young Adults (AYA) into Human Immunodeficiency Virus (HIV)–Related Behavioral Research Studies: A Scoping Review	7
Metabolic Consequences of Antiretroviral Therapy	7
Universal HIV Testing and Treatment (UTT) Integrated with Chronic Disease Screening and Treatment: the SEARCH study	7
Mpox and HIV: a Narrative Review	7
Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy	7
Impact of Antiretroviral Therapy on Cancer Treatment Outcomes among People Living with HIV in Low- and Middle-Income Countries: a Systematic Review	7
Peer Approaches to Improve HIV Care Cascade Outcomes: a Scoping Review Focused on Peer Behavioral Mechanisms	7
Immunologic Control of HIV-1: What Have We Learned and Can We Induce It?	7
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program	6
Consolidated Overview of Notifiable Adverse Events in the U.S. President’s Emergency Plan for AIDS Relief’s Voluntary Medical Male Circumcision Program Through 2020	6
Current Interventions for People Living with HIV Who Use Alcohol: Why Gender Matters	6
Understanding the Evolving Role of Voluntary Medical Male Circumcision as a Public Health Strategy in Eastern and Southern Africa: Opportunities and Challenges	6
Central Nervous System Effects of COVID-19 in People with HIV Infection	6
HIV Compartmentalization in the CNS and Its Impact in Treatment Outcomes and Cure Strategies	6
Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations	6
Immune Dysregulation in Myocardial Fibrosis, Steatosis, and Heart Failure: Current Insights from HIV and the General Population	6
Advances in the Experimental Models of HIV-Associated Neurological Disorders	6